Decision Support in Georgia

Strados Labs is a respiratory-focused clinical trial solutions company delivering regulatory-grade endpoint data for pharmaceutical and biotech sponsors through Phase I–IV trials across 34 countries. The company specializes in continuous, ambulatory respiratory monitoring combined with AI-driven analysis and expert human review to capture disease burden between clinic visits. Product offerings include the Air Next Spirometer (FDA-cleared spirometry with FEV₁, FVC, FEV₁/FVC measurement), RESP® Biosensor (FDA 510(k)-cleared wearable capturing high-fidelity cough, lung sounds, vitals, and activity), RESP® Watch (clinical-trial-ready cough and activity monitoring), NObreath® FeNO (point-of-care fractional exhaled nitric oxide for airway inflammation assessment), and eCOA software suite (ePRO, eClinRO, eObsRO for electronic patient-reported and clinician-reported outcomes). Strados recently acquired NuvoAir's clinical trial business to expand its integrated endpoint platform. All devices are FDA 510(k) cleared, CE-marked, and ISO 13485 certified. The company has accumulated 87,000+ hours of respiratory data across 55+ clinical studies and published 70+ peer-reviewed papers in respiratory research journals including ERJ, CHEST, and npj Digital Medicine. Services include study design consultation, site support, device logistics, and GCP-compliant data delivery. The company serves pharma sponsors and contract research organizations seeking single-vendor respiratory endpoint solutions with retained audio, AI detection paired with expert review, and full audit trails for regulatory submission.

Core Technology Co., Ltd. is a subsidiary of CorDx Union, an international medical diagnostics group established in 2006. The company specializes in in vitro diagnostic (IVD) test kits and point-of-care (POC) testing solutions, serving over 120 countries with more than 1 billion users globally. Product portfolio includes fertility tests, respiratory infectious disease diagnostics, sexual transmitted disease screening, infectious disease panels, cardiac markers, tumor markers, drug-of-abuse screening, and health monitoring tests including blood glucose measurement systems. The company maintains FDA, CE (Conformité Européenne), and NMPA (National Medical Products Administration, China) regulatory certifications for its diagnostic products. Core Technology operates R&D centers, manufacturing facilities, and sales platforms across the United States (California and Georgia headquarters), United Kingdom, Dubai, and Singapore. Manufacturing and quality capabilities are centered in Beijing with industrial facilities exceeding 100,000 square meters. The company participates in major international medical trade shows including Medica, Medlab Asia, and Hospitalar, indicating active engagement in the global clinical diagnostics market.